586
Views
77
CrossRef citations to date
0
Altmetric
Liver and Biliary Tract

Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis

, , , PhD, , , , , & show all
Pages 619-625 | Received 10 Nov 2008, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Yumei Wu, Hui Zeng, Meiping Zhang, Chunyan Li, Yuanlin Tang, Xiufen Li, Shanyou Yuan, Qifeng Wei, Jinghua Wang, Xianjia Ning & Xiaoyin Zhang. (2022) Sex-Specific Risk Factors Associated with Helicobacter pylori Infection Among Individuals Undergoing Health Examinations in China. International Journal of General Medicine 15, pages 5861-5868.
Read now
Xue Wang, Jie Wang, Shujie Wu, Qingwei Ni & Peng Chen. (2021) Association Between the Neutrophil Percentage-to-Albumin Ratio and Outcomes in Cardiac Intensive Care Unit Patients. International Journal of General Medicine 14, pages 4933-4943.
Read now
Saqib Walayat, Daniel Martin, Jaymon Patel, Umair Ahmed, Muhammad N. Asghar, Aparna U. Pai & Sonu Dhillon. (2017) Role of albumin in cirrhosis: from a hospitalist’s perspective. Journal of Community Hospital Internal Medicine Perspectives 7:1, pages 8-14.
Read now
Hammed T. Aiyelabegan, Sadaf S. Z. Zaidi, Songwe Fanuel, Ali Eatemadi, Malihe T. K. Ebadi & Esmaeil Sadroddiny. (2016) Albumin-based biomaterial for lung tissue engineering applications. International Journal of Polymeric Materials and Polymeric Biomaterials 65:16, pages 853-861.
Read now
Peter L. M. Jansen. (2009) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 44:5, pages 516-517.
Read now

Articles from other publishers (72)

Nasser Mousa, Mohamed salah, Sherif Elbaz, Alaa Elmetwalli, Amr Elhammady, Eman Abdelkader, Mostafa Abdelsalam, Niveen El-wakeel, Marwa Mansour, Manal Hashem, Ola El-Emam, Wesam Elderiny, Mohammed Abdelaziz, Ayman Elgamal & Alaa Habib. (2024) Neutrophil percentage-to-albumin ratio is a new diagnostic marker for spontaneous bacterial peritonitis: a prospective multicenter study. Gut Pathogens 16:1.
Crossref
Mohamed A. Heybe & Kosha J. Mehta. (2024) Role of albumin infusion in cirrhosis-associated complications. Clinical and Experimental Medicine 24:1.
Crossref
Mehmet TEKIN, Nimet CINDIK, Mahmut GOKDEMIR, Musa SILAHLI & Mehmet CELIK. (2024) Risk factors for postoperative dialysis in operated congenital heart patients undergoing cardiopulmonary bypass. Gazzetta Medica Italiana Archivio per le Scienze Mediche 183:1-2.
Crossref
Guadalupe Garcia-Tsao, Juan G. Abraldes, Nicole E. Rich & Vincent Wai-Sun Wong. (2024) AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review. Gastroenterology 166:1, pages 202-210.
Crossref
Nijin Wu, Tiantian Liu, Miaomiao Tian, Chenxi Liu, Shujun Ma, Huiling Cao, Hongjun Bian, Le Wang, Yuemin Feng & Jianni Qi. (2023) Albumin, an interesting and functionally diverse protein, varies from ‘native’ to ‘effective’ (Review). Molecular Medicine Reports 29:2.
Crossref
Irina Balazs & Vanessa Stadlbauer. (2023) Circulating neutrophil anti-pathogen dysfunction in cirrhosis. JHEP Reports 5:11, pages 100871.
Crossref
Danielle Adebayo & Florence Wong. (2023) Pathophysiology of Hepatorenal Syndrome – Acute Kidney Injury. Clinical Gastroenterology and Hepatology 21:10, pages S1-S10.
Crossref
Jonel Trebicka & Guadalupe Garcia-Tsao. (2023) Controversies regarding albumin therapy in cirrhosis. Hepatology.
Crossref
Zhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, Andrea Mancuso, Cyriac Abby Philips, Frank Tacke, Metin Basaranoglu, Massimo Primignani, Mostafa Ibrahim, Yu Jun Wong, Filipe Gaio Nery, Rolf Teschke, Carlos Noronha Ferreira, Alberto E. Muñoz, Kanokwan Pinyopornpanish, Thierry Thevenot, Shivaram Prasad Singh, Arpan Mohanty, Sanjaya K. Satapathy, Lorenzo Ridola, Hitoshi Maruyama, Evangelos Cholongitas, Giovanni Battista Levi Sandri, Li Yang, Shalimar, Yongping Yang, Erica Villa, Aleksander Krag, Florence Wong, Rajiv Jalan, Alastair O’Brien, Mauro Bernardi & Xingshun Qi. (2023) Use of albumin infusion for cirrhosis-related complications: An international position statement. JHEP Reports 5:8, pages 100785.
Crossref
Yu Jun Wong & Jing Hong Loo. (2022) Albumin therapy for hepatic encephalopathy: current evidence and controversies. Metabolic Brain Disease 38:5, pages 1759-1763.
Crossref
Kensuke Kitsugi, Kazuhito Kawata, Hidenao Noritake, Takeshi Chida, Kazuyoshi Ohta, Jun Ito, Shingo Takatori, Maho Yamashita, Tomohiko Hanaoka, Masahiro Umemura, Moe Matsumoto & Takafumi Suda. (2023) Rifaximin Improves Liver Functional Reserve by Regulating Systemic Inflammation. Journal of Clinical Medicine 12:6, pages 2210.
Crossref
Caroline L. Matchett, Douglas A. Simonetto & Patrick S. Kamath. (2023) Renal Insufficiency in Patients with Cirrhosis. Clinics in Liver Disease 27:1, pages 57-70.
Crossref
瑶瑶 张. (2023) Application of Albumin in the Treatment of Liver Cirrhosis and Interpretation of the Concept of Effective Albumin. Advances in Clinical Medicine 13:09, pages 14274-14282.
Crossref
Saima Batool, Muhammad Daniyal Waheed, Kiranmayi Vuthaluru, Talha Jaffar, Sameer Krishna Prasad Garlapati, Omair Bseiso, Maira D Nousherwani & Faraz Saleem. (2022) Efficacy of Intravenous Albumin for Spontaneous Bacterial Peritonitis Infection Among Patients With Cirrhosis: A Meta-Analysis of Randomized Control Trials. Cureus.
Crossref
Zhaohui Bai, Le Wang, Ran Wang, Meijuan Zou, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, Gang Cheng & Xingshun Qi. (2022) Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials. Hepatology International 16:6, pages 1468-1483.
Crossref
Mingliang Wang, Tingting Qin, Yunyun Zhang, Ting Zhang, Zirui Zhuang, Yingyu Wang, Yongfang Ding & Yunru Peng. (2022) Toll-like receptor 4 signaling pathway mediates both liver and kidney injuries in mice with hepatorenal syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 323:5, pages G461-G476.
Crossref
Ângelo Zambam de Mattos, Douglas Alano Simonetto, Carlos Terra, Alberto Queiroz Farias, Paulo Lisboa Bittencourt, Tales Henrique Soares Pase, Marlon Rubini Toazza & Angelo Alves de Mattos. (2022) Albumin administration in patients with cirrhosis: Current role and novel perspectives. World Journal of Gastroenterology 28:33, pages 4773-4786.
Crossref
Alex M. Ebied, Thakul Rattanasuwan, Yiqing Chen & Adonice P. Khoury. (2021) Albumin Utilization in Spontaneous Bacterial Peritonitis. Journal of Pharmacy Practice 35:4, pages 546-550.
Crossref
Louise ChinaNatalia BecaresCamilla RheadThais TittanegroNick FreemantleAlastair O'Brien. (2022) Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis. Clinical and Translational Gastroenterology 13:5, pages e00476.
Crossref
Rakesh Kumar Jagdish, Jaswinder Singh Maras & Shiv Kumar Sarin. (2021) Albumin in Advanced Liver Diseases: The Good and Bad of a Drug!. Hepatology 74:5, pages 2848-2862.
Crossref
Irtiza Hasan, Tasnuva Rashid, Razvan M Chirila, Peter Ghali & Hani M. Wadei. (2021) Hepatorenal syndrome: pathophysiology and evidence-based management update. Romanian Journal of Internal Medicine 59:3, pages 227-261.
Crossref
Brian L. Erstad. (2021) Albumin for cirrhosis‐related complications. Journal of Clinical Pharmacy and Therapeutics 46:4, pages 887-894.
Crossref
Abinash Subedi, Vishnu Charan Suresh Kumar, Aakritee Sharma Subedi & Bishnu Sapkota. (2021) A Review of Hepatorenal Syndrome. Cureus.
Crossref
Kok Ban Teh, Jing Hong Loo, Yew Chong Tam & Yu Jun Wong. (2021) Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis. Digestive and Liver Disease 53:7, pages 817-823.
Crossref
Montserrat Costa & Antonio Páez. (2021) Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management. Transfusion and Apheresis Science 60:3, pages 103164.
Crossref
Hee Ho Park, Hyelim Kim, Han Sol Lee, Eun U Seo, Ji-Eun Kim, Jee-Hyun Lee, Yong-Hyeon Mun, So-Yeol Yoo, Jiseon An, Mi-Young Yun, Nae-Won Kang, Dae-Duk Kim, Dong Hee Na, Kyung Soo Hong, Jong Geol Jang, June Hong Ahn, Jong-Sup Bae, Gyu Yong Song, Jae-Young Lee, Hong Nam Kim & Wonhwa Lee. (2021) PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials 273, pages 120827.
Crossref
Saro Khemichian, Claire Francoz, Francois Durand, Constantine J. Karvellas & Mitra K. Nadim. (2021) Hepatorenal Syndrome. Critical Care Clinics 37:2, pages 321-334.
Crossref
Guruprasad P Aithal, Naaventhan Palaniyappan, Louise China, Suvi Härmälä, Lucia Macken, Jennifer M Ryan, Emilie A Wilkes, Kevin Moore, Joanna A Leithead, Peter C Hayes, Alastair J O'Brien & Sumita Verma. (2021) Guidelines on the management of ascites in cirrhosis. Gut 70:1, pages 9-29.
Crossref
Douglas A Simonetto, Pere Gines & Patrick S Kamath. (2020) Hepatorenal syndrome: pathophysiology, diagnosis, and management. BMJ, pages m2687.
Crossref
Ulrich Mayr, Marina Lukas, Mayada Elnegouly, Christine Vogt, Ulrike Bauer, Joerg Ulrich, Roland M. Schmid, Wolfgang Huber & Tobias Lahmer. (2020) Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis. Journal of Clinical Medicine 9:9, pages 2865.
Crossref
Yong-Tao Li, Jian-Rong Huang & Mei-Lian Peng. (2020) Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis. BioMed Research International 2020, pages 1-12.
Crossref
Natalia Becares, Suvi Härmälä, Louise China, Romain A. Colas, Alexander A. Maini, Kate Bennet, Simon S. Skene, Zainib Shabir, Jesmond Dalli & Alastair O’Brien. (2020) Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality. Clinical Gastroenterology and Hepatology 18:5, pages 1207-1215.e6.
Crossref
Juan Carlos Q. Velez, George Therapondos & Luis A. Juncos. (2019) Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis. Nature Reviews Nephrology 16:3, pages 137-155.
Crossref
Andrew J. MacDonald & Constantine J. Karvellas. (2020) Acute kidney injury: A critical care perspective for orthotopic liver transplantation. Best Practice & Research Clinical Anaesthesiology 34:1, pages 69-78.
Crossref
C. Paugam-Burtz, E. Levesque, A. Louvet, D. Thabut, R. Amathieu, C. Bureau, C. Camus, G. Chanques, S. Faure, M. Ferrandière, C. Francoz, A. Galbois, T. Gustot, C. Ichai, P. Ichai, S. Jaber, T. Lescot, R. Moreau, S. Roullet, F. Saliba, T. Thévenot, L. Velly & E. Weiss. (2020) Management of liver failure in general intensive care unit. Anaesthesia Critical Care & Pain Medicine 39:1, pages 143-161.
Crossref
Zhebin You, Tailin Guo, Fan Lin, Chunjin Lin, Jiankang Chen, Xiaoming Li, Yan Chen & Kaiyang Lin. (2019) Fibrinogen-to-Albumin Ratio Predicts Contrast-Induced Nephropathy in Patients after Emergency Percutaneous Coronary Intervention. Cardiology Research and Practice 2019, pages 1-6.
Crossref
Cary H. Paine, Scott W. Biggins & Raimund H. Pichler. (2019) Albumin in Cirrhosis: More Than a Colloid. Current Treatment Options in Gastroenterology 17:2, pages 231-243.
Crossref
Boris Fishman, Vladimir Kulikov, Svetlana Butrimova, Spartak Turmakhanov, Mikhail Yukhno, Irina Prozorova, Pavel Starikov, Oksana Lole & Vyacheslav Zurabov. 2019. Liver Cirrhosis - Debates and Current Challenges. Liver Cirrhosis - Debates and Current Challenges.
Damien Roux, Richard Moreau & Didier Dreyfuss. (2018) Albumin infusion in spontaneous bacterial peritonitis: another brick off the wall?. Annals of Intensive Care 8:1.
Crossref
Cary H. Paine & Raimund H. Pichler. (2018) Treatment of Hyponatremia in End-Stage Liver Disease: New Tools in the Shed. American Journal of Gastroenterology 113:11, pages 1728-1729.
Crossref
Louise China, Alexander Maini, Simon S. Skene, Zainib Shabir, Yvonne Sylvestre, Romain A. Colas, Lucy Ly, Natalia Becares Salles, Vittorio Belloti, Jesmond Dalli, Derek W. Gilroy & Alastair O’Brien. (2018) Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease. Clinical Gastroenterology and Hepatology 16:5, pages 738-747.e7.
Crossref
Toru Shizuma. (2018) Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World Journal of Hepatology 10:2, pages 254-266.
Crossref
Beate Appenrodt & Frank Lammert. (2018) Renal Failure in Patients with Liver Cirrhosis: Novel Classifications, Biomarkers, Treatment. Visceral Medicine 34:4, pages 246-252.
Crossref
Florence Wong. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 262 280.e5 .
Shahid Habib & Obaid S. Shaikh. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 99 116.e6 .
Jui-Hu Hsiao, Cheng-Chung Tsai, Tsung-Jung Liang, Chia-Ling Chiang, Huei-Lung Liang, I-Shu Chen, Yu-Chia Chen, Po-Ming Chang, Nan-Hua Chou & Being-Whey Wang. (2017) Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment. International Journal of Surgery 45, pages 35-41.
Crossref
Yasunari Hiramine, Hirofumi Uto, Yasushi Imamura, Takuya Hiwaki, Takeshi Kure, Sho Ijuin, Kohei Oda, Seiichi Mawatari, Kotaro Kumagai, Koki Tokunaga, Hirofumi Higashi, Ichiro Kanetsuki, Osamu Kubozono, Shigeho Maenohara & Akio Ido. (2016) Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema. Hepatology Research 47:6, pages 542-557.
Crossref
Florence Wong & Paolo Angeli. (2017) New diagnostic criteria and management of acute kidney injury. Journal of Hepatology 66:4, pages 860-861.
Crossref
Philipp Lutz, Hans Dieter Nischalke & Ulrich Spengler. 2017. Biomarkers in Liver Disease. Biomarkers in Liver Disease 977 996 .
A. G. Skuratov, A. N. Lyzikov, E. V. Voropaev & O. V. Osipkina. (2016) INTERLEUKIN-6 AS AN INDICATOR OF SEVERITY OF LIVER CIRRHOSIS AND PORTAL HYPERTENSION. Health and Ecology Issues:4, pages 110-114.
Crossref
Johanna Helmersson‐Karlqvist, Mats Flodin, Aleksandra Mandic Havelka, Xiao Yan Xu & Anders Larsson. (2016) The Roche Immunoturbidimetric Albumin Method on Cobas c 501 Gives Higher Values Than the Abbott and Roche BCP Methods When Analyzing Patient Plasma Samples. Journal of Clinical Laboratory Analysis 30:5, pages 677-681.
Crossref
Rosaria Spinella, Rohit Sawhney & Rajiv Jalan. (2015) Albumin in chronic liver disease: structure, functions and therapeutic implications. Hepatology International 10:1, pages 124-132.
Crossref
Francesco Salerno, Roberta J. Navickis & Mahlon M. Wilkes. (2015) Albumin treatment regimen for type 1 hepatorenal syndrome: a dose–response meta-analysis. BMC Gastroenterology 15:1.
Crossref
Jie Zhang, Guofang Feng, Ying Zhao, Juanwen Zhang, Limin Feng & Jing Yang. (2015) Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study. BMJ Open 5:8, pages e008033.
Crossref
T.‐Y. Renn, Y.‐H. Kao, C.‐C. Wang & T. Burnouf. (2015) Anti‐inflammatory effects of platelet biomaterials in a macrophage cellular model. Vox Sanguinis 109:2, pages 138-147.
Crossref
Rita Garcia‐Martinez, Lorette Noiret, Sambit Sen, Rajeshwar Mookerjee & Rajiv Jalan. (2014) Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver International 35:2, pages 335-343.
Crossref
Christian Ertmer, Tim‐Gerald Kampmeier, Thomas Volkert, Heiner Wolters, Sebastian Rehberg, Andrea Morelli, Hartmut Schmidt, Matthias Lange, Matthias Boschin, Hugo Van Aken & Klaus Hahnenkamp. (2014) Impact of human albumin infusion on organ function in orthotopic liver transplantation – a retrospective matched‐pair analysis. Clinical Transplantation 29:1, pages 67-75.
Crossref
Philipp Lutz, Hans Dieter Nischalke & Ulrich Spengler. 2016. Biomarkers in Liver Disease. Biomarkers in Liver Disease 1 20 .
John More & Mark Bulmer. 2013. Production of Plasma Proteins for Therapeutic Use. Production of Plasma Proteins for Therapeutic Use 159 183 .
Paolo Caraceni, Marco Domenicali, Alessandra Tovoli, Lucia Napoli, Carmen Serena Ricci, Manuel Tufoni & Mauro Bernardi. (2013) Clinical indications for the albumin use: Still a controversial issue. European Journal of Internal Medicine 24:8, pages 721-728.
Crossref
Rita Garcia-Martinez, Paolo Caraceni, Mauro Bernardi, Pere Gines, Vicente Arroyo & Rajiv Jalan. (2013) Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 58:5, pages 1836-1846.
Crossref
Puneeta Tandon, Deepali Kumar, Yeon Seok Seo, Hsiu-Ju Chang, Jennifer Chaulk, Michelle Carbonneau, Hina Qamar, Adam Keough, Nadia Mansoor & Mang Ma. (2013) The 22/11 Risk Prediction Model: A Validated Model for Predicting 30-Day Mortality in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis. American Journal of Gastroenterology 108:9, pages 1473-1479.
Crossref
Francesco Salerno, Roberta J. Navickis & Mahlon M. Wilkes. (2013) Albumin Infusion Improves Outcomes of Patients With Spontaneous Bacterial Peritonitis: A Meta-analysis of Randomized Trials. Clinical Gastroenterology and Hepatology 11:2, pages 123-130.e1.
Crossref
Heejung Choi, Yoonjung Kim, Soo Min Kim, Junam Shin, Hye Ryoun Jang, Jung Eun Lee, Wooseong Huh, Yoon-Goo Kim, Ha Young Oh & Dae Joong Kim. (2012) Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT. Kidney Research and Clinical Practice 31:2, pages 106-111.
Crossref
Tsung–Hsing Hung, Chen–Chi Tsai, Yu–Hsi Hsieh, Chih–Chun Tsai, Chih–Wei Tseng & Jai–Jen Tsai. (2012) Effect of Renal Impairment on Mortality of Patients With Cirrhosis and Spontaneous Bacterial Peritonitis. Clinical Gastroenterology and Hepatology 10:6, pages 677-681.
Crossref
Kazunari Kaneko, Takahisa Kimata, Shoji Tsuji, Tomohiko Shimo, Masaya Takahashi & Sachiyo Tanaka. (2011) Serum albumin level accurately reflects antioxidant potentials in idiopathic nephrotic syndrome. Clinical and Experimental Nephrology 16:3, pages 411-414.
Crossref
Maria Poca, Mar Concepción, Meritxell Casas, Cristina Álvarez–Urturi, Jordi Gordillo, Virginia Hernández–Gea, Eva Román, Carlos Guarner–Argente, Ignasi Gich, German Soriano & Carlos Guarner. (2012) Role of Albumin Treatment in Patients With Spontaneous Bacterial Peritonitis. Clinical Gastroenterology and Hepatology 10:3, pages 309-315.
Crossref
Alexander R. Bonnel, Chalermrat Bunchorntavakul & K. Rajender Reddy. (2011) Immune Dysfunction and Infections in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology 9:9, pages 727-738.
Crossref
Jia Duo & Julie A. Stenken. (2010) Heparin-immobilized microspheres for the capture of cytokines. Analytical and Bioanalytical Chemistry 399:2, pages 773-782.
Crossref
M. Joannidis & C. J. Wiedermann. 2011. Annual Update in Intensive Care and Emergency Medicine 2011. Annual Update in Intensive Care and Emergency Medicine 2011 233 241 .
Christian J. Wiedermann, Wolfgang Wiedermann & Michael Joannidis. (2010) Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Medicine 36:10, pages 1657-1665.
Crossref
Albert Farrugia. (2010) Albumin Usage in Clinical Medicine: Tradition or Therapeutic?. Transfusion Medicine Reviews 24:1, pages 53-63.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.